EBRAINS as a driver for research and development in Europe
In this session, EBRAINS Joint CEO Philippe Vernier will highlight EBRAINS pivotal role in advancing research and innovation across Europe. As a digital research infrastructure at the forefront of brain research, EBRAINS empowers scientists with tools and data, fostering collaboration across disciplines and border. This session will underscore EBRAINS’ contributions to European scientific leadership, its impact on health and technology sectors, and its strategic importance in shaping neuroscience.
Who You’ll Be Hearing From
This session brings together expert voices from across the EBRAINS community and beyond. Discover the people sharing their insights, research, and perspectives on the topic.
%20CEA%20(1).jpg)
%20CEA%20(1).jpg)
Since July 2023, Philippe Vernier has served as Joint CEO of EBRAINS. He is an Emeritus Research Director of Exceptional Class at the French National Centre for Scientific Research (CNRS) and Scientific Advisor at CEA Paris-Saclay. He is a specialist in brain development and its evolution. His research focuses on the evolution of the brain and neuromodulatory neurotransmission systems, as well as the evolution of cognitive functions such as language, memory, and emotions. His work also addresses neurological conditions such as Parkinson’s disease and Attention Deficit Hyperactivity Disorder (ADHD). Philippe Vernier previously led the Frédéric Joliot Institute for Life Sciences at the CEA Saclay Center (2019-2024). Prior to that, he was the director of the Paris-Saclay Institute of Neuroscience (NeuroPSI), which he founded (2015–2019). A former neurology resident at hospitals of Grenoble, Philippe Vernier was trained in neuroscience and molecular biology at Claude Bernard University (Lyon) and Pierre and Marie Curie University (Paris).